CompuGroup Medical SE & Co. KGaA (COP:XETRA) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the CompuGroup Medical SE & Co. KGaA stock forecast from 0 analysts, the average analyst target price for CompuGroup Medical SE & Co. KGaA is not available over the next 12 months. CompuGroup Medical SE & Co. KGaA’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CompuGroup Medical SE & Co. KGaA is Slightly Bearish, which is based on 6 positive signals and 9 negative signals. At the last closing, CompuGroup Medical SE & Co. KGaA’s stock price was EUR 30.50. CompuGroup Medical SE & Co. KGaA’s stock price has changed by +2.01% over the past week, +9.71% over the past month and -37.96% over the last year.
No recent analyst target price found for CompuGroup Medical SE & Co. KGaA
No recent average analyst rating found for CompuGroup Medical SE & Co. KGaA
Company Overview CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. The company's Ambulatory Information Systems segment develop and sell practice management software for registered physicians, medical care centers, and physician networks; and offers supplementary internet and intranet solutions. Its Pharmacy Information Systems segment develop and sell administrative and billing related software applications, which includes procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies. Hospital Information Systems segment develop and sells of clinical and administrative solutions for inpatient sector; healthcare services to acute care hospitals, rehabilitation centers, welfare institutions, multi-location hospital networks, healthcare regions, regional care organizations, medical laboratories, and radiologists. The Consumer & Health Management Information Systems segment provides software interfaces for data exchange, portals for retrieving data from the German outpatient healthcare market, medical decision support tools, medication and treatment databases for healthcare service providers, solutions for the insurance industry, and digital healthcare applications, consumer portals, and mobile apps; and operates telematics infrastructure business, which offers secure links, as well as security solutions for service providers. The company was founded in 1987 and is headquartered in Koblenz, Germany. Address: Maria Trost 21, Koblenz, Germany, 56070 Read Less
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. The company's Ambulatory Information Systems segment develop and sell practice management software for registered physicians, medical care center...Read More
Frequently Asked Questions About CompuGroup Medical SE & Co. KGaA (COP:XETRA) Stock
Stock Target Advisor's fundamental analysis for CompuGroup Medical SE & Co. KGaA's stock is Slightly Bearish.
COP:XETRA stock's dividend yield is 3.27%.
Our analysis grades COP:XETRA stock's dividend yield at F. This means that COP:XETRA stock's dividend yield is above 50% of the stocks in the Health Information Services sector in the XETRA exchange.
Based on this COP:XETRA may be a average dividend stock for its sector.
Unfortunately we do not have enough data on COP:XETRA's stock to indicate what its average analyst target is.
COP:XETRA stock's Price/Earning ratio is 34.75.
Our analysis grades COP:XETRA stock's Price / Earning ratio at F. This means that COP:XETRA stock's Price/Earning ratio is above 50% of the stocks in the Health Information Services sector in the XETRA exchange.
Based on this COP:XETRA may be fairly valued for its sector
The last closing price of COP:XETRA's stock was EUR 30.50.
The most recent market capitalization for COP:XETRA is EUR 1.60B.
Unfortunately we do not have enough analyst data on COP:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CompuGroup Medical SE & Co. KGaA's stock.
As per our most recent records CompuGroup Medical SE & Co. KGaA has 9,199 Employees.
CompuGroup Medical SE & Co. KGaA's registered address is Maria Trost 21, Koblenz, Germany, 56070.
You can get more information about it from CompuGroup Medical SE & Co. KGaA's website at https://www.cgm.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for COP:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
